Studies on clinical specimens of breast cancer revealed that high expression levels of the AMAP1 protein as well as the co-overexpression of GEP100 with EGFR correlate well with their malignant and invasive phenotypes [21,23]. The gene discussed is ASAP1; the disease is breast cancer.